Giredestrant (GDC-9545, RG6171) is an orally active, selective estrogen receptor degrader (SERD) with best-in-class potential to compete with estradiol in the ER ligand binding domain and induce conformational changes.Giredestrant has antitumor activity.
Molecular Weight:
522.55
Purity:
>99.0%
CAS Number:
[1953133-47-5]
Formula:
C27H31F5N4O
Target:
Estrogen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
